When more is not better: treatment intensification among hypertensive patients with poor medication adherence.
about
Providing physicians with feedback on medication adherence. Effect on processes of care and patient outcomesThe concept and definition of therapeutic inertia in hypertension in primary care: a qualitative systematic reviewHow well do we care for patients with hypertension?Coronary heart disease risk factors and outcomes in the twenty-first century: findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) StudyPriority Setting and Influential Factors on Acceptance of Pharmaceutical Recommendations in Collaborative Medication Reviews in an Ambulatory Care Setting - Analysis of a Cluster Randomized Controlled Trial (WestGem-Study)Association of Continuity of Primary Care and Statin AdherenceImproving treatment intensification to reduce cardiovascular disease risk: a cluster randomized trial.A quality improvement plan for hypertension control: the INCOTECA Project (INterventions for COntrol of hyperTEnsion in CAtalonia).Comparing methods of measuring treatment intensification in hypertension careDepression and clinical inertia in patients with uncontrolled hypertension.EDUCORE project: a clinical trial, randomised by clusters, to assess the effect of a visual learning method on blood pressure control in the primary healthcare setting.Single-Pill Combination of Perindopril/Indapamide/Amlodipine in Patients with Uncontrolled Hypertension: A Randomized Controlled Trial.Clinically relevant quality measures for risk factor control in primary care: a retrospective cohort study.First Things First: Difficulty with Current Medications Is Associated With Patient Willingness to Add New OnesTreatment intensification and risk factor control: toward more clinically relevant quality measures.Multiple uncontrolled conditions and blood pressure medication intensification: an observational study.Quasi-experimental trial of diabetes Self-Management Automated and Real-Time Telephonic Support (SMARTSteps) in a Medicaid managed care plan: study protocol.Aliskiren for the treatment of essential hypertension under real-life practice conditions: design and baseline data of the prospective 3A registry.Study protocol: the Adherence and Intensification of Medications (AIM) study--a cluster randomized controlled effectiveness studyPhysician assessments of medication adherence and decisions to intensify medications for patients with uncontrolled blood pressure: still no better than a coin toss.Multicenter cluster-randomized trial of a multifactorial intervention to improve antihypertensive medication adherence and blood pressure control among patients at high cardiovascular risk (the COM99 study)Good knowledge about hypertension is linked to better control of hypertension; a multicentre cross sectional study in Karachi, PakistanHypertension and depression: coexisting barriers to medication adherenceBlood pressure trajectories and associations with treatment intensification, medication adherence, and outcomes among newly diagnosed coronary artery disease patients.Mental illness and intensification of diabetes medications: an observational cohort studyMeta-analysis: impact of drug class on adherence to antihypertensives.Hypertension treatment intensification among stroke survivors with uncontrolled blood pressure.Effects of daily adherence to antihypertensive medication on blood pressure controlAn overview of management issues in adult patients with type 2 diabetes mellitus.Cost implications of improving blood pressure management among U.S. adultsPatient-reported racial/ethnic healthcare provider discrimination and medication intensification in the Diabetes Study of Northern California (DISTANCE).An integrated approach to preventing cardiovascular disease: community-based approaches, health system initiatives, and public health policyPharmacist intervention for blood pressure control: medication intensification and adherence.Poor drug adherence and lack of awareness of hypertension among hypertensive stroke patients in Kampala, Uganda: a cross sectional studyPredicting Risk of End-Stage Liver Disease in Antiretroviral-Treated Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected PatientsRelationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study.Reach and Validity of an Objective Medication Adherence Measure Among Safety Net Health Plan Members with Diabetes: A Cross-Sectional Study.A clinically guided approach for improving performance measurement for hypertension.The complex relationship between CKD and ambulatory blood pressure patterns.The association between medication adherence and treatment intensification with blood pressure control in resistant hypertension
P2860
Q24186763-1917A350-F745-434F-80A9-EF98D624328CQ26864018-B6246756-BCBA-4AF0-9CBA-6AFC8014F1CBQ27006514-70E154CF-650F-4F23-9186-55C72640E69AQ27026525-ADF747A6-E017-4905-B32D-3CC3DD45DB0AQ28552615-3BE1A569-D546-450E-AB90-4AD80DDADDF7Q28606627-D9CC326D-765D-46ED-A754-B639ECBCAEE5Q31070536-A9C17920-E42D-44A1-91B6-02168E0E02C3Q33422160-E2204EDE-0C32-488A-9655-C7E8935D6D4AQ33572437-D8D79BDE-06F6-445D-B5E7-2AC5A8D2EB47Q33578926-2B21277A-2E9A-40A7-A554-02F1B6B2C453Q33645866-292D6A44-B9EF-43F6-9763-9CF4C96ED84CQ33734032-D447991D-A5AF-4D5F-B3DC-EE7F3C4BEDC0Q33929231-F33F0C0A-1A90-4141-8E3E-9D178097E336Q33985188-F517B0F0-2006-46E3-8536-C13D6E0C9010Q33988413-55E7B0B6-88EF-4100-A307-2C91A533CF02Q34036648-590F3299-2F03-4B5C-96D5-52047A75CCBFQ34142191-B0DA8A2A-FD3B-4082-8144-740528886421Q34155229-7258872B-57F7-4261-B754-AE3B6696C3B2Q34258198-94A6C34C-F6CF-4A90-AF59-19F4B38F70C2Q34386912-A4E6325B-4327-4AB9-9787-45A74F1E061BQ34402022-CB2D4E14-18EC-473E-8C46-AF8E23DF2C62Q34457120-CD8E6870-0C17-4145-B01E-2880DB0B5DC6Q34632402-69CD04FA-7AD1-4D9A-8AB0-AE2CCD29C721Q34753242-925A1E3C-5C29-4CE1-89DD-1C70284F4F53Q34806586-924ADC43-4BCE-4BD4-A443-32237B5F2096Q34887070-402CEF0B-306E-437B-82F2-82FF8CDD2301Q35019512-7AC6405B-2E9B-477E-8E50-DBF66AA66144Q35037085-045F6BBC-7B9D-4242-A263-A0F94DB73BBBQ35075959-CE788727-9708-493F-A223-0E1BB30C15DAQ35190993-69D55F51-9E8D-4ADF-A5BE-CD6233AB9AFCQ35235522-870B85E8-5A40-4996-8E9F-8A2103A4CE49Q35727709-97E64926-A662-4550-80FD-7B3E9A0875C9Q35868070-B391B59D-5950-45CD-8387-7FC7331C9474Q35883483-F69009F5-0F14-41BA-AEB9-D3DC70BA59FBQ35952818-2C39BC83-B411-4CF2-A8F9-13D2A015BF9FQ36006322-FF72BAD5-0771-4087-BBC6-A93B4A476126Q36006414-7E55B198-BBCE-4808-A5A0-A3BA83A05E8BQ36011456-28EABA45-969B-42DA-9635-F422D8FF7A71Q36100474-5FA51007-6E83-4567-A16A-75B0B9220DD0Q36178338-150519FF-C0F4-49A9-B61E-4851CB0D0AB7
P2860
When more is not better: treatment intensification among hypertensive patients with poor medication adherence.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
When more is not better: treat ...... ith poor medication adherence.
@en
When more is not better: treat ...... ith poor medication adherence.
@nl
type
label
When more is not better: treat ...... ith poor medication adherence.
@en
When more is not better: treat ...... ith poor medication adherence.
@nl
prefLabel
When more is not better: treat ...... ith poor medication adherence.
@en
When more is not better: treat ...... ith poor medication adherence.
@nl
P2093
P1433
P1476
When more is not better: treat ...... ith poor medication adherence.
@en
P2093
Eve A Kerr
Julie A Schmittdiel
Manel Pladevall
Mary M Hogan
Timothy P Hofer
P304
P356
10.1161/CIRCULATIONAHA.107.724104
P407
P577
2008-05-27T00:00:00Z